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Abstract
Background: In South Africa (SA), stroke is the second highest cause of mortality and disability. Apart from being
the main killer and cause of disability, stroke is an expensive disease to live with. Stroke costs include death and
medical costs. Little is known about the stroke burden, particularly the stroke direct costs in SA. Identification of
stroke costs predictors using appropriate statistical methods can help formulate appropriate health programs and
policies aimed at reducing the stroke burden. Analysis of stroke costs have in the main, concentrated on mean
regression, yet modelling with quantile regression (QR) is more appropriate than using mean regression. This is
because the QR provides flexibility to analyse the stroke costs predictors corresponding to quantiles of interest. This
study aims to estimate stroke direct costs, identify and quantify its predictors through QR analysis.
Methods: Hospital-based data from 35,730 stroke cases were retrieved from selected private and public hospitals
between January 2014 and December 2018. The model used, QR provides richer information about the predictors
on costs. The prevalence-based approach was used to estimate the total stroke costs. Thus, stroke direct costs were
estimated by taking into account the costs of all stroke patients admitted during the study period. QR analysis was
used to assess the effect of each predictor on stroke costs distribution. Quantiles of stroke direct costs, with a focus
on predictors, were modelled and the impact of predictors determined. QR plots of slopes were developed to
visually examine the impact of the predictors across selected quantiles.
Results: Of the 35,730 stroke cases, 22,183 were diabetic. The estimated total direct costs over five years were R7.3
trillion, with R2.6 billion from inpatient care. The economic stroke burden was found to increase in people with
hypertension, heart problems, and diabetes. The age group 55–75 years had a bigger effect on costs distribution at
the lower than upper quantiles.
Conclusions: The identified predictors can be used to raise awareness on modifiable predictors and promote
campaigns for healthy dietary choices. Modelling costs predictors using multivariate QR models could be beneficial
for addressing the stroke burden in SA.
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Background
Stroke is the second leading cause of death and the third
leading cause of long-term disability worldwide [1]. This
imposes a huge economic burden [2]. Further, non-
communicable diseases (NCDs) are currently accounting
for 74% of all deaths and long-term disability. Most of
these deaths (8.9 million) are due to cardiovascular dis-
eases such as ischemic heart disease and stroke [3].
More than 80% of the stroke burden occurs in low and
middle-income countries, and reliable data on stroke
epidemiology and modelling predictors of stroke direct
costs are scarce in these settings [4]. The burden of
NCD including stroke was also found to be on the rise
in Africa and other low and middle-income country
(LMIC) settings [5]. In Sub-Saharan Africa (SSA) which
includes SA, the burden is on the rise owing to increas-
ing incidences. SSA has the highest stroke incidence of
316/ 100,000 person-years [1]. Moreover, there are
young stroke patients in SSA, resulting in a greater num-
ber of years of potential productivity and years of life
lost (YLL). The high social and economic burden of
stroke calls for effective strategies for prevention, treat-
ment, and rehabilitation in SSA [6]. Even though stroke
can be prevented and treated, it remains one of the big-
gest cause of death and long-term disability globally [1].
Stroke is increasingly becoming a major public health
issue among adults, especially in developing countries
like SA [7]. In SA, stroke is the second highest cause of
mortality after HIV/AIDS and is among the top ten lead-
ing cause of long-term disability [8], accounting for
25,000 deaths a year and 95,000 years lived with disabil-
ity (YLD) [8]. Also, the crude stroke mortality was found
to be 114 per 100,000 person-years and contributed to
8.7% years lived with disability (YLDs) in the Agincourt
sub-district rural area in SA [8]. The crude stroke inci-
dence of 244/ 100,000 person-years was also quoted for
SA [9]. Mudzi et al. [10] showed that 25.5% of stroke pa-
tients die within three months and 38% within 12
months of hospital discharge in SA. Literature indicates
that numerous studies have been focusing on the indir-
ect costs of stroke in different nations including SA.
Stroke costs can be classified as direct or indirect costs
with indirect costs including death and disability. The
majority of studies [1, 11, 12] conducted to examine pre-
dictors of indirect costs in several countries used statis-
tical models which might not be optimal to inform
targeted cost-effective policies and early interventions
because they focus solely on the conditional mean of the
response variable distribution. Thus, ordinary linear re-
gression models could not give enough information
about the underlying associations, and is not robust to
statistical outliers and lacks flexibility in analysing the
predictors of stroke direct costs [13]. Modelling the
mean as in ordinary linear regression models could miss
critical aspects of the relationship that may exist be-
tween stroke direct costs and its predictors, especially in
the presence of skewed data as is usually the case with
cost of illness data [14].
However, not enough is known about modelling pre-
dictors of stroke direct costs in SA using the quantile re-
gression (QR) statistical technique. This paper addresses
important gaps in the stroke disease literature, utilising
data collected between January 2014 and December
2018 in SA. To fill these gaps, this study aims to esti-
mate stroke direct costs, identify and quantify modifiable
and non-modifiable predictors of stroke direct costs
through QR analysis. The information generated from
this study is intended to guide the planning of health
services for stroke prevention and management in SA.
Methods
Data
Data were collected between January 2014 and Decem-
ber 2018. The study sites consist of the nine provinces
of SA with an estimate of the mid-year population of
57.73 million [17]. There are approximately 407 public
and 203 private hospitals in SA [18]. This study ran-
domly selected 55% of the 203 private hospitals in all
provinces and 45% of the 407 public hospitals were ran-
domly selected across the nine provinces of SA. A strati-
fied probability sampling technique was used to
calculate the proportions accordingly. The strata being
public and private hospitals. Thus, study data were re-
trieved from 183 public and 112 private hospitals, mak-
ing a total of 295 hospitals. Although most South
Africans use public hospitals, many of these institutions
did not capture good quality pertinent variables while
private hospitals were doing so. The proportions used
were based on the availability of study variables in the
public and private hospital databases, and the total num-
ber of private and public hospitals in SA. Therefore, 55%
of the data were retrieved from private hospitals and
45% from public hospitals.
According to the South African National Department
of Health [18], SA private and public health systems
exist in parallel [18]. The majority of the population use
public hospitals, despite being chronically under-funded
and under-staffed whilst 20% of the population use pri-
vate hospitals [18]. Further, the National Department of
Health manages 10 major teaching hospitals.
A validated data retrieval sheet was used to retrieve
study data. Patients’ medical records were reviewed to
elicit all medical healthcare services consumed during
stroke hospitalisation and out of the hospital. The data
retrieval sheet was formulated with all the study vari-
ables which include; mode of admission, that is inpatient
or outpatient, stroke risk factors that are non-
modifiable, and those that are modifiable, and direct
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costs. The variable type of hospital, that is private or
public hospital was anonymous for ethical reasons which
meant there was no variable specifying type of hospital
admitted, as agreed upon in advance. The study hospi-
tals were sampled from the nine provinces of SA, namely
Gauteng, KwaZulu-Natal, Western Cape, Eastern Cape,
North West, Free State, Limpopo, Mpumalanga, and
Northern Cape. The case managers for the sampled hos-
pitals assisted with data retrieval. The total number of
stroke patients was 35,730.
Study variables
Dependent variable
The outcome variable was stroke total direct costs mea-
sured on a continuous scale over five years. Inflation was
ignored over this short period. Inflation in South Africa
was low over the period. Evidenced by figures reported
in a Stats SA [15] reports for consumer price index
2014–2018. The inflation rate for 2014 was (6.09%),
2015 (4.58%), 2016 (6.35%), 2017 (5.27%) and 2018
(4.62%).
Independent/explanatory variables
This study considered several explanatory variables
based on the literature on factors influencing stroke dir-
ect costs, especially in developing countries. Factors con-
sidered include modifiable, non-modifiable and direct
medical costs items.
Diabetes was defined as a fasting glucose concentra-
tion of greater than 7.0 mmol/L, cholesterol was defined
as fasting cholesterol concentration of at least 5.2 mmol/
L, high-density lipoproteins (HDL) cholesterol at least
1.03 mmol/L, and low-density lipoproteins (LDL) choles-
terol of at least 3.4 mmol/L. Whilst hypertension was de-
fined with cut off of 140/90 mmHg for up to 72 h and
heart problems were defined as current atrial fibrillation,
heart failure, ischemic heart disease, and valvular heart
diseases [1]. The modifiable risk factors of stroke coded
as 0 = no, if the measurement is below the defined value
of interest and 1 = yes, if the measurements exceeded
the study definition. The race variable in SA is cate-
gorised as whites, blacks, coloureds, Indians and Asians.
This study combined Indians, and Asians to be one ra-
cial group because of the lower numbers.
Direct medical costs were defined as the medical cost
of managing stroke disease, the direct medical costs in-
clude (diagnosis, inpatient/ hospitalisation and out-
patient care, chronic medication, radiological
examination computed tomography (CT) or magnetic
resonance image (MRI), allied services such as physio-
therapy and speech therapy, physician, neurologist, clin-
ical treatment and laboratory examination cost). All
such information was collated over the five years. Direct
costs include all stroke patients that are suspected of or
have confirmed stroke.
Estimation of direct costs
Direct costs of stroke were estimated by using a
prevalence-based approach. The prevalence-based ap-
proach estimates the costs of all stroke cases in a given
study period [16]. The study direct costs include all
medical costs for stroke disease incurred within the five-
year study period. These costs included hospitalisation/
inpatient care costs, diagnostic costs, outpatient costs,
and prevention costs. Direct costs of patient transport
were not included. Productivity losses as a result of time
off work due to illness or due to caring for a stroke pa-
tient were also not included as these are indirect costs.
Thus, this study estimated the total stroke direct costs
by taking into account the direct costs of all stroke pa-
tients admitted during the five-year study period. The
cost of an inpatient stay was calculated as documented
in the Provincial Gazette, Department of Health (2015).
The per-item cost of inpatient stays included hospital
bed cost, health professional services e.g. nursing ser-
vices, physicians, and therapists’ costs. The hourly costs
of specialists were obtained from the department of
health salary scales. The amount of time by physicians,
physiotherapists, occupational, and speech therapists per
patient per day was taken from the Provincial Gazette.
Also, besides the total direct treatment costs for in-
patient care, diagnostic visits and tests, and surgical
treatment were estimated by multiplying the calculated
number of incident stroke cases with the relevant treat-
ment costs. Based on the department of health gazette,
the frequency of outpatient visits was assumed over the
year for each patient, after being discharged from the
hospital. The unit cost of the stroke outpatient clinic
was taken from the gazette. The chronic medication
costs were estimated from private and public hospital
pharmacies.
Statistical analyses
Data were analysed using descriptive statistics expressing
continuous variables through the mean with their corre-
sponding coefficient of skewness. Categorical variables
were presented as frequencies and their associated per-
centages. In this paper, two models were used, ordinary
least squares (OLS) and quantile regression. QR is a
modelling technique which commonly use the median
regression and estimate the conditional quantiles whilst
OLS method focus on the conditional mean [13, 19]. QR
analysis was employed to assess the effect of modifiable
and non-modifiable risk factors on stroke direct costs.
Modelling of stroke direct costs was done to develop a
predictive and a descriptive model. Thus, QR leads to
more comprehensive results because of its ability to
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assess the effect of each predictor at any part of the
stroke direct costs distribution, whereas linear regression
can model only the conditional mean of the stroke direct
costs. Since costs data has a skewed distribution, QR
analysis was employed because it allows for the study of
relationships for extreme (low or high) costs [13]. To
examine the effects of predictors at different points of
the distribution of stroke direct costs, this study used a
QR model developed by Aheto [13].
The response variable of interest is stroke direct costs
denoted by Y, and X is a vector of explanatory variables.
We can model the τ quantile of Y conditional on Xi =
(xi0′xi1′xi2′…. . xip) using the QR model given as QyijXiðτj
XiÞ = xTi βτ (1).
Where, QyijXi (τ| Xi) is the conditional τ
th quantile out-
come given xi, τ ∈ (0, 1) is the τ
th quantile of the out-
come variable stroke direct costs. The variable
XTi ¼ ðxi00xi10xi20…::xipÞT is the vector of covariates for
each individual i and βTτ = (βτ0, βτ1, βτ2,…βτp)
T is the
vector of (p + 1) regression coefficients at the known τ,
and τ is the 0.1, 0.25, 0.50, 0.75, and 0.95 quantiles. The
formulation in (1) permits the modelling of two or more
quantiles of stroke direct costs simultaneously while
adjusting for the observed covariates [13]. Multivariate
QR models were fitted to the stroke direct costs data.
The results in Table 4 are graphically displayed in Fig. 1.
The quantile plots of predictor effects on the quantiles
of stroke direct costs in the model permit visual examin-
ation of the predictor effects on each quantile. For ana-
lysis, IBM SPSS Version 26 was used to conduct
frequencies on demographic and lifestyle characteristics
of stroke patients and the R statistical software version
4.0.4. was used for QR analysis of stroke costs. The QR
coefficient estimates for the stroke direct costs were also
produced with the aid of R statistical package namely
quantreg written by Aheto [13] and Koenker [19]. The
results from the model were used to examine the covari-
ate effects on each quantile.
Results
The main demographic characteristics of stroke patients
are shown in Table 1. A total of 35,730 stroke patients
were retrieved from the patient admission records.
Fig. 1 Quantile regression plot of predictors effect on quantiles of stroke direct costs distribution. Note: XAge_DC2 = Age group 55–75 years,
XAge_DC3 = Age group 76–98 years, XIndianasian_2 = Indian/Asian-race, XIndianasian_3 = Black race, XIndianasian_4 = Coloured race
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There were slightly more females (50.8%) than males.
Most patients were whites (34.3%) followed by blacks
(29.6%) and fewer coloureds (14.6%). The remainder be-
ing Indian/Asian. The average age at the stroke onset
was 54.3 years. The incidence of stroke has shown a
trend towards relatively younger people in SA with an
average age of 54.3 years. A large proportion of patients
were relatively young evidenced by 54.5% of patients
aged 18–54 years. On average patients were hospitalised
for nearly 20 days. The three most common modifiable
risk factors were diabetes (62.1%), hypertension (55.3%),
and heart problems (54.4%).
The cost figures are summarised in Table 2. Direct
costs include medication cost, physiotherapy cost,
speech therapy cost, outpatient cost and inpatient/hospi-
talisation costs for all stroke patients and the total direct
costs were (R7.3 trillion over the 5 years). The mean
total medication cost per patient was R65 680.02 over
the 5 years. The total inpatient care costs (R2.6 billion
per 5 -year period) were significantly higher among fe-
males with hypertension, cholesterol, heart problems,
and diabetes. The average cost of speech therapy was ap-
proximately (R329.1 million per 5- year period). There
were no patients with zero costs, see Table 2. The mean
outpatient cost was relatively low (R33 761.27 per 5-year
period). The major drivers for direct costs in SA were
inpatient care cost (35%), medication cost (32%), and
physiotherapy cost (32%). Further, study findings also
show that stroke direct costs data were not normally dis-
tributed as indicated by the coefficient of skewness
greater than zero. Thus, stroke direct cost data was
skewed to the right tail of the cost distribution.
Table 3 depicts positive intercept for the ordinary least
squares linear regression model, entailing that for our
basis, a relatively young white male without hyperten-
sion, cholesterol, heart problems, and diabetes, with no
known other costs and was not hospitalised incurs total
stroke direct costs of R 488 (for fixed/admin costs, etc.).
The effect of non-modifiable on stroke direct costs is
positive and significantly stronger except for the
coloured race which is insignificantly different from the
basis. The positive coefficients entail that the female
gender, higher age groups, other races (Indian/Asians,
and blacks) increase stroke direct costs when compared
to the basis. Furthermore, modifiable predictors of
stroke such as hypertension, cholesterol, heart problems,
and diabetes increase stroke direct costs. The effect of
diabetes on stroke direct costs are bigger than the effect
of other modifiable predictors. Also, the inpatient care
effect on stroke direct costs is bigger than the effect of
the other cost items. The positive and significant coeffi-
cient for inpatient care, outpatient care, medication,
Table 1 Demographic characteristics of stroke patients and
possible predictors (n = 35,730)



























Length of stay in hospital (LOS) 19.78 days
Table 2 Direct costs of stroke in South Africa for the period 2014–2018 (Costs in South African Rands)
Cost items N Estimated cost % Average cost Skewness coefficient
Medication cost 35,730 2,346,747,100 32 65,680.02 1.178
Physiotherapy cost 35,730 2,348,398,831 32 65,726.25 2.096
Speech-therapy cost 35,730 1,175,724,668 16 32,905.81 2.191
Outpatient cost 35,730 1,206,290,175 16 33,761.27 0.837
Inpatient cost 35,730 2,594,616,496 35 72,617.31 1.907
Total direct costs 35,730 7,347,348,497,641 205,282.67
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physiotherapy, and speech-therapy cost entails that for
every one-unit increase for any cost item, stroke direct
costs increases by the amount of the coefficient shown
in Table 3.
Table 4 shows positive intercepts for the five QR
models, implying that for our basis, a relatively
young white male without hypertension, cholesterol,
heart problems, and diabetes, with no known other
costs and was not hospitalised incurs total stroke
direct costs of R 1, 150 (for fixed/admin costs, etc.)
in the 10th quantile. The other intercepts can be
interpreted similarly. The quantile regression results
show significant differences between lower and upper
quantiles. The magnitude of the association between
non-modifiable and stroke direct costs fluctuate
across all the quantiles. The effect of non-modifiable
on stroke direct costs is positive and significantly
stronger at the 75th and 95th quantiles except for
the coloured race which is insignificantly different
from the basis at the 10th quantile. The positive co-
efficients entail that the female gender, higher age
groups, other races (Indian/Asians, and blacks) in-
crease stroke direct costs when compared to the
basis. Moreover, modifiable predictors of stroke such
as hypertension, cholesterol, heart problems, and dia-
betes increase stroke direct costs across all the quan-
tiles. The effect of cholesterol and heart problems
Table 3 Results of ordinary least squares linear regression
analysis for predictors of stroke direct costs
Variable Coefficient (βj) 95% CI for βj P-value
Intercept 0.488 (0.450,0.490) < 0.0001
Age group 55–75 years 0.799 (0.698,0.809) < 0.0001
Age group 76–98 years 1.724 (1.700,1.735) < 0.0001
Female-gender 1.306 (1.300,1.310) < 0.0001
Indian/Asian-race 1.495 (1.417,1.505) < 0.0001
Black-race 1.837 (1.800,1.840) < 0.0001
Coloured-race 2.169 (−2.100,2.209) 0.987
Hypertension-yes 1.152 (1.100,1.202) < 0.0001
Cholesterol-yes 0.588 (0.549,0.608) < 0.0001
Heart problems-yes 1.203 (1.199,1.215) < 0.0001
Diabetes-yes 2.207 (2.204,2.210) < 0.0001
Chronic medication-cost 1.236 (1.137,1.240) < 0.0001
Hospitalisation-cost 2.999 (1.980,3.000) < 0.0001
Outpatient-cost 1.676 (1.566,1.680) < 0.0001
Physiotherapy-cost 2.090 (1.600,1.706) < 0.0001
Speech therapy-cost 0.987 (2.000,2.109 < 0.0001
Note: βj= coefficient, 95%CI = 95% confidence interval
Table 4 Results of Multivariate quantile regression analysis for predictors of stroke direct costs
Variables Quantiles τ
τ = 0.1 τ = 0.25 τ=0.5 τ= 0.75 τ = 0.95
βj 95% CI of βj βj 95% CI of βj βj 95% CI of βj βj 95% CI of βj βj 95% CI of βj
Intercept 1.152*** (1.150,1.155) 1.702*** (1.601,1.721) 2.740*** (2.709,2.745) 2.870*** (2.670,2.900) 1.587*** (1.580,1.600)
Female-gender 1.020*** (1.000,1.300) 2.100*** (1.999,2.345) 1.999*** (1.980,2.000) 0.987*** (0.897,1.12) 2.981*** (2.890,3.008)
Age group
55–75 years
1.217*** (1.200,1.220) 1.113*** (1.110,1.118) 1.563*** (1.556,1.600) 1.946*** (1.941,1.956) 1.008*** (1.000,1.113)
Age group
76–98 years
1.531*** (1.430,1.630) 1.804*** (1.800,1.987) 1.738*** (1.730,1.745) 1.940*** (1.899,1.989) 1.227*** (1.117,1.312)
Indian/Asian-race 2.000*** (0.999,2.10) 1.093*** (1.090,1.246) 1.738*** (1.678,1.741) 1.357*** (1.346,1.455) 1.880*** (1.788,1.908)
Black-race 1.551*** (1.457,1.601) 2.500*** (2.167,2.560) 1.986*** 1.980,2.100) 1.984*** (1.982,1.999) 1.315*** (1.301,1.412)
Coloured-race 2.698 (−2.598,2.708) 2.470 (−2.430,2.500) 1.476 (−1.46,1.56) 3.423 (−3.404,3.523) 1.553 (−1.550,1.555)
Hypertension-yes 3.249*** (3.200,3.250) 2.157*** (2.100,2.200) 3.419*** (3.314,3.519) 2.528*** (2.428,2.556) 3.230*** (3.123,3.340)
Cholesterol-yes 2.511*** (1.519,2.545) 2.612*** (2.610,2.810) 2.510*** (2.455,2.567) 2.257*** (2.250,2.307) 1.049*** (1.044,1.056)
Heart problems-yes 3.149*** (3.129,3.250) 2.418*** (2.319,2.420) 2.981*** (2.980,3.100) 3.201*** (3.199,3.389) 2.295*** (2.195,2.305)
Diabetes-yes 4.213*** (4.205,5.200) 3.214*** (3.115,3.250) 2.846*** (2.840,2.855) 2.589*** (2.458,2.609) 3.553*** (3.500,3.633)
Hospitalisation-cost 4.189*** (4.109,4.190) 1.989*** (1.900,2.109) 1.000*** (0.899,1.201) 1.283*** (1.183,1.294) 2.788*** (2.688,2.808)
Outpatient-cost 1.000*** (0.998,1.100) 1.715*** (1.700,1.812) 1.936*** (1.914,1.956) 2.415*** (2.399,2.546) 1.607*** (1.606,1.610)
Medication-cost 1.486*** (1.398,1.506) 1.416*** (1.400,1.420) 1.274*** (1.266,1.298) 1.117*** (1.100,1.207) 1.775*** (1.700,1.805)
Physiotherapy-cost 1.186*** (1.109,1.190) 1.065*** (1.054,1.070) 2.902*** (2.900,2.912) 2.889*** (2.880,2.909) 1.725*** (1.720,1.743)
Speech therapy-cost 1.026*** (0.978,1.342) 1.817*** (1.619,1.817) 1.967*** (1.890,2.070) 2.129*** (2.109,2.234) 1.725*** (1.712,1.730)
Note: τ= quantile, βj= coefficient, 95%CI = 95% confidence interval, *p < 0.05, **p < 0.01, ***p < 0.0001. All coefficients are per 5-year period
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on stroke direct costs are bigger at the 10th quan-
tiles with less effect at the upper quantiles, whilst
diabetes effect on stroke direct costs are bigger at
the lower and upper quantiles and less effect at the
50th quantile. Hypertension costs are more or less
uniform across all quantiles. The effect of inpatient
care on stroke direct costs is bigger at the 10th
quantile. However, other cost items have a bigger ef-
fect on stroke direct costs at the 95th quantile. The
positive and significant coefficient for inpatient care,
outpatient care, medication, physiotherapy, and
speech-therapy cost entails that for every one-unit
increase for any cost item, stroke direct costs in-
creases by the amount of the coefficient. The param-
eters, in this quantile regression model, including
modifiable, non-modifiable, and cost items predictors
are positive and significant, thus confirming their
greater impact on stroke direct cost distribution
when compared with the basis.
Figure 1 above presents a concise visual summary
of the estimated quantile regression results of the
stroke direct costs predictors. Each plot illustrates
the effect of one of the explanatory variables in the
quantile regression model. The dash-dot-dot curve
with filled dots represents the 19 point estimates of
the coefficient for ’s ranging from 0.05 to 0.95. In
this regard, τ is representing different quantiles. The
shaded grey area shows a 95% pointwise confidence
band. Superimposed on the plot is a solid red line
representing the ordinary least squares of the mean,
with two dashed red lines representing a 95% confi-
dence interval for a particular coefficient [14]. Each
plot is showing different quantiles on the x-axis and
the covariate effect on the y-axis. Results illustrated
in each plot are similar to those shown in Table 4.
The results have shown that QR models provided
much more information about the underlying associ-
ations better than the ordinary least regression, sug-
gesting that the conditional distribution of stroke
direct costs did not only differ by their means but
also by their lower and upper tails. Thus, the ordin-
ary least squares regression missed critical aspects of
the associations that exist between the conditional
distributions of the stroke direct costs and its pre-
dictors as shown in Fig. 1. For instance, the impact
of age group 55–75 years on stroke direct costs were
higher at the upper quantiles and lower, at the lower
quantiles of the stroke direct costs. Further, the im-
pact of female gender on stroke direct costs was
higher at the lower and upper quantiles of the distri-
bution of the costs. The magnitude of the associ-
ation for physiotherapy cost increases from low to
high quantiles. This result implies that the physio-
therapy cost effect on stroke direct costs was much
larger at the upper end (extremes) than the lower
and central locations.
Discussion
This study identified and quantified predictors of stroke
direct costs in SA, using quantile regression to elucidate
the differential effects of each putative predictor on
stroke direct costs. The important drivers of stroke dir-
ect costs were the female gender, higher age groups, In-
dian/Asian, and black races, hypertension, cholesterol,
heart problems, diabetes, medication, inpatient/hospital-
isation, outpatient, physiotherapy, and speech therapy
costs. The study results have shown that quantile regres-
sion models provided richer information about the
underlying associations better than the ordinary least
squares regression, signifying that conditional distribu-
tions of stroke direct costs did not only differ by their
means but also by their lower, central location and
upper tails as reported in previous studies. Diringer et al.
[20] also found old age, heart problem, male sex, the se-
verity of the stroke, and hospitalisation as predictors of
ischemic stroke hospital costs. Similar findings were re-
vealed by a study done in the UK, which found that the
mean stroke costs were higher in females aged between
75 and 84 years [21]. A study conducted in the
Netherlands established that hospitalisation costs con-
tributed a larger proportion to total stroke costs and age
was significantly associated with stroke costs [22]. A Ko-
rean study concluded that elderly men, inpatient and
outpatient cost contributed the highest proportion to
direct costs of stroke [23]. Stroke costs were found to be
higher in men than those in women ([23, 24]. The study
broadly supports earlier studies that investigated risk
factors of stroke costs in developing countries. Elderly
people, females, blacks and factors such as hypertension,
cholesterol, heart problems, and diabetes increased the
risk of stroke. Further, black South Africans had a higher
impact on stroke direct costs than whites. Reducing the
burden of stroke in the SA population requires identifi-
cation of non-modifiable risk factors of stroke and dem-
onstration of the efficacy of the risk reduction effort and
impact on costs. Since the risky gender group has been
identified in SA, this study recommends campaign ser-
vices on raising awareness of the dangers of stroke risk,
targeting the female gender and riskier groups.
Apart from non-modifiable factors being significantly
associated with stroke direct costs, modifiable predictors
such as hypertension, cholesterol, heart problems, and
diabetes were also found to be significantly associated
with stroke direct costs. The mean stroke medical costs
were found to be higher in men aged ±68.8 years with
hypertension and cholesterol [25]. Wang et al. [24]
found that hypertension and diabetes were associated
with higher costs. A Lebanese study identified the cost
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drivers for stroke direct medical cost as the severity of
the stroke, length of stay in hospital (LOS), male sex,
hypertension, cholesterol, diabetes, Atrial fibrillation,
and smoking [25].
A study conducted in Finland also found that elderly
females with hypertension, heart disease and diabetes
were more expensive than men [26]. Largely comorbidi-
ties such as hypertension, cholesterol, heart problems,
smoking, and diabetes are the major drivers for stroke
direct costs. The study recommends regular screening
and testing and treatment of hypertension, cholesterol,
heart problems and diabetes in SA to detect the risk of
stroke early enough.
The study has several important findings, hospitalisa-
tion, medication, and physiotherapy costs contributed a
larger proportion to total stroke direct costs in SA. A Da-
nish study also found the attributable costs of direct net
health care services after stroke as age, gender, general
practitioner services, hospital services, and medication
[27]. Saka et al. [28] found that larger proportions for
stroke direct costs in the UK were from diagnosis costs,
inpatient care costs, outpatient care costs, and drug costs.
Inpatient treatment and medication costs significantly
contributed to the health care costs for stroke patients
[27]. Numerous studies found, LOS, intensive care unit,
stroke severity, old age, male gender and comorbidities
such as hypertension, cholesterol, diabetes and heart prob-
lems as the major drivers of the direct medical cost of hos-
pitalisation for stroke [24, 25, 29]. Overall, inpatient costs,
outpatient costs and medication costs were identified as
the major contributors to stroke direct medical costs. The
finding that the proportion of hospitalisation cost was
higher than other proportions of stroke cost items is con-
sistent with previous studies [12, 25].
There were some limitations to this study. Risk factors
such as stress, HIV/AIDS, smoking and alcohol consump-
tion were not captured in the patient’s records. Clinical se-
verity factors such as neurologic severity were not
available in the data, yet it is an important predictor of
costs. The indirect costs due to loss of productivity and
family members’ informal care were not examined since
the data set did not include this information. Further stud-
ies could consider including all risk factors of stroke and
examining the indirect costs for a more comprehensive
evaluation of stroke costs. Nevertheless, the strengths of
this prevalence-based cost of illness study lie in that all
cases of stroke are included for the specific period 2014 to
2018. Also, recent data set has been used without missing
information. To date, this is the only comprehensive QR
study on modelling the direct costs of stroke in SA.
Conclusion
This study provides useful insights for healthcare pro-
grams and policies on the risk of hypertension,
cholesterol, heart problems and diabetes in SA. The sig-
nificance of comorbidities of stroke should be examined
further to identify and treat groups at high risk of devel-
oping stroke so that its costs and consequences for pa-
tients and families can be reduced in SA. It further
highlights the need for more improved health awareness
efforts to increase knowledge of modifiable stroke pre-
dictors in the South African population, and to support
healthy life-style choices among South Africans. Thus,
reporting the average costs of stroke without an account
of these factors may be pointless when assessing the
cost-effectiveness of stroke interventions. More broadly,
we hope that our detailed cost information on stroke pa-
tients could be used to develop cost-effective programs
for preventing this epidemic while simultaneously redu-
cing the stroke economic burden.
The estimated cost is expected to provide an evidential
source for use in determining cost-effective policies on
management stroke and making plans for arranging
medical sources as well as to determine priorities for the
effective prevention of stroke and national healthcare
policies. Although stroke is a disease of ageing, we found
a high prevalence of stroke in relatively young people.
This is worrying because a large proportion of product-
ive working age group is affected in SA, we recommend
further studies to understand the reasons for the new
trend of relatively young strokes. The identified predic-
tors can aid the formulation of healthcare policies and
early interventions that will improve stroke outcomes
and reduce costs. Thus, this study calls for early inter-
ventions and treatment of hypertension, cholesterol and
diabetes in SA. The identification of more vulnerable
groups can be used to formulate more effective interven-
tions for these groups. Finally, the use of quantile regres-
sion modelling technique is recommended for
identifying and quantifying stroke direct costs predictors
because quantile regression leads to more comprehen-
sive results because of its ability to assess the effect of
each predictor at any part of the outcome distribution.
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